Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Capital Expenditures (2022 - 2025)

Centessa Pharmaceuticals has reported Capital Expenditures over the past 4 years, most recently at $11000.0 for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to $11000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $279000.0 through Dec 2025, up 720.59% year-over-year, with the annual reading at $371000.0 for FY2025, 991.18% up from the prior year.
  • Capital Expenditures was $11000.0 for Q4 2025 at Centessa Pharmaceuticals, down from $234000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $652000.0 in Q4 2022 and troughed at $10000.0 in Q2 2023.
  • The 4-year median for Capital Expenditures is $43000.0 (2023), against an average of $144090.9.
  • Year-over-year, Capital Expenditures plummeted 95.71% in 2023 and then skyrocketed 588.24% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $652000.0 in 2022, then plummeted by 95.71% to $28000.0 in 2023, then increased by 21.43% to $34000.0 in 2024, then crashed by 67.65% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Capital Expenditures are $11000.0 (Q4 2025), $234000.0 (Q3 2025), and $34000.0 (Q3 2024).